Charles River Laboratories International Total Liabilities

Charles River Laboratories International (CRL) currently reports a total liabilities of $4.7B as of March 2026. That compares with $4.3B in the prior-year period — up 9.2% year over year. Use the charts on this page to explore Charles River Laboratories International's total liabilities history and peer comparisons.

Charles River Laboratories International's total liabilities increased from $4.3B to $4.7B — a 9.2% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Charles River Laboratories International reported $4.7B in total liabilities as of March 2026. That compares with $4.3B in the prior-year period — up 9.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $4.7B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Charles River Laboratories International, and consider following CRL for alerts when major investors trade the stock.

Charles River Laboratories International is classified in the Healthcare sector. On total liabilities, it currently shows $4.7B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CRL with unrelated industries.